IPO News: Aptinyx Prices 5.3mm Share IPO at $16, the top of the $14.00 - $16.00 Marketing Range



Initial Filing Date: 05/23/18

Launch Date: 06/11/18

Pricing Date: 06/21/18

IPO Price: $16.00

Price Range: $14.00 - $16.00

Shares Offered (Pre-Shoe | mm): 5.3

Primary Shares (mm): 5.3

Secondary Shares (mm): 0

Amount Offered (mm): $112.0

% Secondary: 0.0%

Shares Outstanding (mm): 31.5

Market Value at Pricing (mm): $660.9

Offering as % of Market Value: 16.9%

Bookrunners: J.P. Morgan | Cowen | Leerink | BMO

Major Holder(s): Adams Street Partners | New Leaf Ventures | Longitude Venture Partners | Frazier Life Sciences | Bain Capital Life Sciences \ LVP Life Science Ventures

Industry: Healthcare

Description: Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders.

Note: Emerging Growth Company